BRIEF published on 05/02/2024 at 10:51, 1 year 10 months ago Urban-gro, Inc Maintains Buy Rating from First Berlin Equity Research Amidst Cannabis Rescheduling News Cannabis Industry Stock Market Urban-gro Inc Investment Analysis Cannabis Rescheduling
BRIEF published on 05/02/2024 at 10:51, 1 year 10 months ago Urban-gro, Inc maintient la note d'achat de la première recherche sur les actions de Berlin au milieu des nouvelles sur le rééchelonnement du cannabis Bourse Industrie Du Cannabis Analyse Des Investissements Urban-gro Inc. Reprogrammation Du Cannabis
PRESS RELEASE published on 05/02/2024 at 10:46, 1 year 10 months ago Original-Research: urban-gro, Inc (von First Berlin Equity Research GmbH): Kaufen First Berlin Equity Research reaffirms BUY rating on urban-gro, Inc. following DEA's approval of cannabis rescheduling, anticipating positive effects on sector and company. Full year targets confirmed First Berlin Equity Research Investment Urban-gro Inc Cannabis Rescheduling Sector Sentiment
BRIEF published on 04/30/2024 at 22:10, 1 year 10 months ago Urban-gro, Inc. Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance Financial Results Adjusted EBITDA Revenue Growth Urban-gro Expense Management
BRIEF published on 04/30/2024 at 22:10, 1 year 10 months ago Urban-gro, Inc. publie ses résultats financiers du premier trimestre 2024 et réaffirme ses prévisions pour l'année 2024 Résultats Financiers EBITDA Ajusté Hausse Des Revenus Urban-gro Gestion Des Dépenses
PRESS RELEASE published on 04/30/2024 at 22:05, 1 year 10 months ago urban-gro, Inc. Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance urban-gro, Inc. reports Q1 2024 financial results showing revenue growth and cost reduction. Conference call scheduled. Company remains optimistic about industry reforms Financial Results Revenue Growth Cost Reduction Urban-gro Inc. Industry Reforms
BRIEF published on 04/15/2024 at 14:35, 1 year 11 months ago Urban-gro, Inc. Announces Q1 2024 Earnings Call on April 30 Financial Results Conference Call Q1 2024 Earnings Urban-gro Controlled Environment Agriculture
BRIEF published on 04/15/2024 at 14:35, 1 year 11 months ago Urban-gro, Inc. annonce l'appel aux résultats du premier trimestre 2024 le 30 avril Résultats Financiers Conférence Téléphonique Urban-gro Résultats Du 1er Trimestre 2024 Agriculture En Environnement Contrôlé
PRESS RELEASE published on 04/15/2024 at 14:30, 1 year 11 months ago urban-gro, Inc. to Report First Quarter 2024 Financial Results on April 30, 2024 urban-gro, Inc. (NASDAQ:UGRO) to report Q1 2024 financial results on April 30, 2024. Conference call at 4:30 p.m. ET. Details at https://ir.urban-gro.com/news-events/ Conference Call NASDAQ:UGRO Urban-gro Inc. Q1 2024 Financial Results Controlled Environment Agriculture
BRIEF published on 04/04/2024 at 16:46, 1 year 11 months ago First Berlin Equity Research Maintains Buy Rating for urban-gro, Inc Despite Q4 Challenges Cannabis Industry First Berlin Equity Research Stock Rating Urban-gro Inc Investment Analysis
Published on 03/26/2026 at 21:00, 42 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 42 minutes ago Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 16:20, 5 hours 22 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 8 hours 42 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 20:48, 53 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 2 hours 21 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 2 hours 32 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 2 hours 32 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 3 hours 25 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 3 hours 25 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 3 hours 42 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 3 hours 42 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
